Saroja Pharma Industries Complete Financial Statements
SAROJA • Review detailed financials to uncover trends, confirm thesis & journal trades
5 Years of Data
2025 - 2021
Complete Financial Data Export
Export complete financial statements for Saroja Pharma Industries (SAROJA).
Downloads include all available records across all periods.
For market performance, see the
SAROJA stock price today
.
Profitability Ratios
Net Profit Margin
1.85%
2025 data
EBITDA Margin
5.56%
2025 data
Operating Margin
5.00%
2025 data
Return on Assets
2.50%
2025 data
Return on Equity
6.25%
2025 data
Balance Sheet Ratios
Current Ratio
27.00
2025 data
Debt to Equity
2.50
2025 data
Equity Ratio
40.00%
2025 data
Asset Turnover
1.35
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
-100.0%
Year-over-Year
Net Profit Growth
-100.0%
Year-over-Year
EBITDA Growth
-100.0%
Year-over-Year
Expense Growth
-100.0%
Year-over-Year
Assets Growth
+48.1%
Year-over-Year
Equity Growth
+6.7%
Year-over-Year
Liabilities Growth
+48.1%
Year-over-Year
Investing Cash Flow Growth
+40.0%
Year-over-Year
Financing Cash Flow Growth
-50.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 54 | 41 | 50 | 56 | 37 |
| Expenses | 0 | 51 | 38 | 48 | 54 | 35 |
| EBITDA | 0 | 3 | 3 | 3 | 2 | 1 |
| Operating Profit Margin % | 0.00% | 5.00% | 6.00% | 5.00% | 4.00% | 4.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 1 | 1 | 1 | 1 | 0 |
| Profit Before Tax | 0 | 1 | 1 | 2 | 2 | 1 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 1 | 1 | 1 | 1 | 1 |
| Earnings Per Share (₹) | 0.00 | 2.57 | 2.49 | 3.61 | 3.96 | 2.69 |
Related Pages for Saroja Pharma Industries
Additional stock information and data for SAROJA
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| ASSETS | |||||
| Total Assets | 40 | 27 | 21 | 16 | 8 |
| Current Assets | 27 | 18 | 16 | 15 | 8 |
| Fixed Assets | 3 | 3 | 2 | 0 | 0 |
| Capital Work in Progress | 9 | 6 | 2 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 28 | 18 | 17 | 15 | 8 |
| LIABILITIES | |||||
| Total Liabilities | 40 | 27 | 21 | 16 | 8 |
| Current Liabilities | 1 | 3 | 3 | 2 | 1 |
| Non-Current Liabilities | |||||
| SHAREHOLDERS' EQUITY | |||||
| Total Equity | 16 | 15 | 5 | 4 | 1 |
| Share Capital | 4 | 4 | 3 | 0 | 0 |
| Reserves & Surplus | 12 | 11 | 2 | 4 | 1 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 |
|---|---|---|---|---|---|
| Operating Activities | 1 | 1 | 2 | -4 | -1 |
| Investing Activities | -3 | -5 | -5 | 0 | 0 |
| Financing Activities | 2 | 4 | 3 | 4 | 1 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 |